LOC728024 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.038400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.900800E-01
Normal-vs-Stage2
1.060790E-01
Normal-vs-Stage3
2.396400E-01
Normal-vs-Stage4
7.987400E-01
Stage1-vs-Stage2
2.559000E-01
Stage1-vs-Stage3
1.880630E-01
Stage1-vs-Stage4
7.246600E-01
Stage2-vs-Stage3
1.091950E-01
Stage2-vs-Stage4
1.502250E-01
Stage3-vs-Stage4
1.285160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.456800E-01
Normal-vs-AfricanAmerican
1.852790E-01
Normal-vs-Asian
2.304200E-01
Caucasian-vs-AfricanAmerican
6.301400E-01
Caucasian-vs-Asian
3.534600E-01
AfricanAmerican-vs-Asian
8.274000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.925400E-01
Normal-vs-Female
4.380800E-01
Male-vs-Female
6.381400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.544600E-01
Normal-vs-Age(41-60Yrs)
8.970600E-01
Normal-vs-Age(61-80Yrs)
2.024800E-01
Normal-vs-Age(81-100Yrs)
1.727630E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.483800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.588600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.999800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.401700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.234400E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.871500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.146980E-01
Normal-vs-Daily Drinker
6.191800E-01
Normal-vs-Weekly Drinker
1.544780E-01
Normal-vs-Occasional Drinker
9.346400E-01
Normal-vs-Social Drinker
8.060600E-01
Non Drinker-vs-Daily Drinker
2.212000E-01
Non Drinker-vs-Weekly Drinker
4.550200E-01
Non Drinker-vs-Occasional Drinker
5.620500E-02
Non Drinker-vs-Social Drinker
1.955990E-01
Daily Drinker-vs-Weekly Drinker
5.116600E-01
Daily Drinker-vs-Occasional Drinker
3.218200E-01
Daily Drinker-vs-Social Drinker
7.221000E-01
Weekly Drinker-vs-Occasional Drinker
1.267770E-01
Weekly Drinker-vs-Social Drinker
3.787200E-01
Occasional Drinker-vs-Social Drinker
5.857200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.993400E-01
Normal-vs-Grade 2
3.962000E-01
Normal-vs-Grade 3
2.822400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.682450E-01
Grade 1-vs-Grade 3
2.245400E-01
Grade 1-vs-Grade 4
4.993400E-01
Grade 2-vs-Grade 3
6.518800E-01
Grade 2-vs-Grade 4
3.962000E-01
Grade 3-vs-Grade 4
2.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.143600E-01
Normal-vs-NonDiabetic
4.243800E-01
Diabetic-vs-NonDiabetic
5.961800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.496400E-02
Normal-vs-NoPancreatitis
4.489400E-01
Pancreatitis-vs-NoPancreatitis
9.660100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.577000E-01
Normal-vs-N1
1.339440E-01
N0-vs-N1
3.056600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.226000E-02
Normal-vs-TP53-NonMutant
7.098000E-01
TP53-Mutant-vs-TP53-NonMutant
3.319800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
